Cargando…
Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients
SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus-2), cause of COVID-19 (Coronavirus Disease of 2019), represents a significant risk to people living with pre-existing conditions associated with exacerbated inflammatory responses and consequent dysfunctional immunity. In this paper, we have...
Autores principales: | Frasca, Daniela, Reidy, Lisa, Cray, Carolyn, Diaz, Alain, Romero, Maria, Kahl, Kristin, Blomberg, Bonnie B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990309/ https://www.ncbi.nlm.nih.gov/pubmed/33760825 http://dx.doi.org/10.1371/journal.pone.0245424 |
Ejemplares similares
-
The majority of SARS-CoV-2-specific antibodies in COVID-19 patients with obesity are autoimmune and not neutralizing
por: Frasca, Daniela, et al.
Publicado: (2021) -
Phenotypic and Functional Characterization of Double Negative B Cells in the Blood of Individuals With Obesity
por: Frasca, Daniela, et al.
Publicado: (2021) -
Obesity accelerates age defects in B cells, and weight loss improves B cell function
por: Frasca, Daniela, et al.
Publicado: (2023) -
Metformin Enhances B Cell Function and Antibody Responses of Elderly Individuals With Type-2 Diabetes Mellitus
por: Frasca, Daniela, et al.
Publicado: (2021) -
Secretion of autoimmune antibodies in the human subcutaneous adipose tissue
por: Frasca, Daniela, et al.
Publicado: (2018)